100 algorithm-development-"Multiple"-"Simons-Foundation" research jobs at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
mentoring and career development. The 2021 Research Excellence Framework (REF2021) placed King’s applied and allied health research 1st for: overall proportion of research rated 4* (world-leading, the best
-
class of signalling molecule that acts during embryonic development to generate a variety of cell states. In response to distinct threshold levels of morphogen signalling, cells follow different fates and
-
challenges and pressing environmental, geopolitical, urban and rural issues. Our research findings contribute to public debates and policy development at national and international scales, making important
-
This exciting research role will be responsible for the successful delivery and future development of a newepilepsy research project jointly run by King’s College London and Swansea University and funded by
-
A morphogen is a special class of signalling molecule that acts during embryonic development to generate a variety of cell states. In response to distinct threshold levels of morphogen signalling
-
on mentoring and career development. The School hosts the British Heart Foundation Centre of Research Excellence at King's, which brings together a unique range of internationally recognised scientists
-
for basic-clinical interaction and a strong focus on mentoring and career development. The School hosts the British Heart Foundation Centre of Research Excellence at King's, which brings together a unique
-
development and pro and antisocial behaviours. We believe it is essential to investigate the determinants of typical development in order to understand variation in behaviour (or illness). About the role We
-
bringing together leading experts in brain development. We believe it is essential to investigate the determinants of normal development and we bring together expertise in basic animal models, the latest
-
bacterial infections. About the role The bacterial pathogen Klebsiella pneumoniae (Kp) is a major antibiotic-resistant pathogen responsible for high levels of mortality worldwide. Development of novel